BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 33997750)

  • 41. Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production.
    Rodrigues CM; Fan G; Wong PY; Kren BT; Steer CJ
    Mol Med; 1998 Mar; 4(3):165-78. PubMed ID: 9562975
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Decreasing mitochondrial fission prevents cholestatic liver injury.
    Yu T; Wang L; Lee H; O'Brien DK; Bronk SF; Gores GJ; Yoon Y
    J Biol Chem; 2014 Dec; 289(49):34074-88. PubMed ID: 25342755
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prevention of bile acid-induced apoptosis by betaine in rat liver.
    Graf D; Kurz AK; Reinehr R; Fischer R; Kircheis G; Häussinger D
    Hepatology; 2002 Oct; 36(4 Pt 1):829-39. PubMed ID: 12297830
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Four-And-A-Half LIM-Domain Protein 2 (FHL2) Deficiency Aggravates Cholestatic Liver Injury.
    Sommer J; Dorn C; Gäbele E; Bataille F; Freese K; Seitz T; Thasler WE; Büttner R; Weiskirchen R; Bosserhoff A; Hellerbrand C
    Cells; 2020 Jan; 9(1):. PubMed ID: 31963815
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatoprotection by the farnesoid X receptor agonist GW4064 in rat models of intra- and extrahepatic cholestasis.
    Liu Y; Binz J; Numerick MJ; Dennis S; Luo G; Desai B; MacKenzie KI; Mansfield TA; Kliewer SA; Goodwin B; Jones SA
    J Clin Invest; 2003 Dec; 112(11):1678-87. PubMed ID: 14623915
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Resistance of rat hepatocytes against bile acid-induced apoptosis in cholestatic liver injury is due to nuclear factor-kappa B activation.
    Schoemaker MH; Gommans WM; Conde de la Rosa L; Homan M; Klok P; Trautwein C; van Goor H; Poelstra K; Haisma HJ; Jansen PL; Moshage H
    J Hepatol; 2003 Aug; 39(2):153-61. PubMed ID: 12873810
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Knockout of α-calcitonin gene-related peptide attenuates cholestatic liver injury by differentially regulating cellular senescence of hepatic stellate cells and cholangiocytes.
    Wan Y; Ceci L; Wu N; Zhou T; Chen L; Venter J; Francis H; Bernuzzi F; Invernizzi P; Kyritsi K; Baker P; Huang Q; Wu C; Sybenga A; Alpini G; Meng F; Glaser S
    Lab Invest; 2019 Jun; 99(6):764-776. PubMed ID: 30700848
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Fine-Tuning of Sirtuin 1 Expression Is Essential to Protect the Liver From Cholestatic Liver Disease.
    Blokker BA; Maijo M; Echeandia M; Galduroz M; Patterson AM; Ten A; Philo M; Schungel R; Gutierrez-de Juan V; Halilbasic E; Fuchs C; Le Gall G; Milkiewicz M; Milkiewicz P; Banales JM; Rushbrook SM; Mato JM; Trauner M; Müller M; Martínez-Chantar ML; Varela-Rey M; Beraza N
    Hepatology; 2019 Feb; 69(2):699-716. PubMed ID: 30229970
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cholestasis confers resistance to the rat liver mitochondrial permeability transition.
    Lieser MJ; Park J; Natori S; Jones BA; Bronk SF; Gores GJ
    Gastroenterology; 1998 Sep; 115(3):693-701. PubMed ID: 9721167
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of farnesoid X receptor in determining hepatic ABC transporter expression and liver injury in bile duct-ligated mice.
    Wagner M; Fickert P; Zollner G; Fuchsbichler A; Silbert D; Tsybrovskyy O; Zatloukal K; Guo GL; Schuetz JD; Gonzalez FJ; Marschall HU; Denk H; Trauner M
    Gastroenterology; 2003 Sep; 125(3):825-38. PubMed ID: 12949728
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Protective effects of n-Butanol extract and iridoid glycosides of Veronica ciliata Fisch. Against ANIT-induced cholestatic liver injury in mice.
    Hua W; Zhang S; Lu Q; Sun Y; Tan S; Chen F; Tang L
    J Ethnopharmacol; 2021 Feb; 266():113432. PubMed ID: 33011367
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inhibition of intestinal bile acid absorption improves cholestatic liver and bile duct injury in a mouse model of sclerosing cholangitis.
    Baghdasaryan A; Fuchs CD; Österreicher CH; Lemberger UJ; Halilbasic E; Påhlman I; Graffner H; Krones E; Fickert P; Wahlström A; Ståhlman M; Paumgartner G; Marschall HU; Trauner M
    J Hepatol; 2016 Mar; 64(3):674-81. PubMed ID: 26529078
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Repetitively hypoxic preconditioning attenuates ischemia/reperfusion-induced liver dysfunction through upregulation of hypoxia-induced factor-1 alpha-dependent mitochondrial Bcl-xl in rat.
    Chou PL; Chen KH; Chang TC; Chien CT
    Chin J Physiol; 2020; 63(2):68-76. PubMed ID: 32341232
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Novel role of macrophage TXNIP-mediated CYLD-NRF2-OASL1 axis in stress-induced liver inflammation and cell death.
    Zhan Y; Xu D; Tian Y; Qu X; Sheng M; Lin Y; Ke M; Jiang L; Xia Q; Kaldas FM; Farmer DG; Ke B
    JHEP Rep; 2022 Sep; 4(9):100532. PubMed ID: 36035360
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of cholestasis and NeuroAid treatment on the expression of Bax, Bcl-2, Pgc-1α and Tfam genes involved in apoptosis and mitochondrial biogenesis in the striatum of male rats.
    Nasehi M; Torabinejad S; Hashemi M; Vaseghi S; Zarrindast MR
    Metab Brain Dis; 2020 Jan; 35(1):183-192. PubMed ID: 31773435
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early transcriptional deregulation of hepatic mitochondrial biogenesis and its consequent effects on murine cholestatic liver injury.
    Tiao MM; Lin TK; Liou CW; Wang PW; Chen JB; Kuo FY; Huang CC; Chou YM; Chuang JH
    Apoptosis; 2009 Jul; 14(7):890-9. PubMed ID: 19462240
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antinecrotic and antiapoptotic effects of hepatocyte growth factor on cholestatic hepatitis in a mouse model of bile-obstructive diseases.
    Li Z; Mizuno S; Nakamura T
    Am J Physiol Gastrointest Liver Physiol; 2007 Feb; 292(2):G639-46. PubMed ID: 17068118
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ursodeoxycholic acid loaded dual-modified graphene oxide nanocomposite alleviates cholestatic liver injury through inhibiting hepatocyte apoptosis.
    Zhou W; Yang X; Yin Y; Chen S; Yang L; Li T; Liu J; Lu B; Yang Z; Li R; Zhang M
    Colloids Surf B Biointerfaces; 2024 Jun; 238():113904. PubMed ID: 38603845
    [TBL] [Abstract][Full Text] [Related]  

  • 59. MicroRNA-210 Promotes Bile Acid-Induced Cholestatic Liver Injury by Targeting Mixed-Lineage Leukemia-4 Methyltransferase in Mice.
    Kim YC; Jung H; Seok S; Zhang Y; Ma J; Li T; Kemper B; Kemper JK
    Hepatology; 2020 Jun; 71(6):2118-2134. PubMed ID: 31549733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma biomarkers of liver injury and inflammation demonstrate a lack of apoptosis during obstructive cholestasis in mice.
    Woolbright BL; Antoine DJ; Jenkins RE; Bajt ML; Park BK; Jaeschke H
    Toxicol Appl Pharmacol; 2013 Dec; 273(3):524-31. PubMed ID: 24096036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.